These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10847471)

  • 1. Ten-year survival in advanced malignant melanoma following treatment with interferon and vindesine.
    Iqbal M; Marshall E; Green JA
    Ann Oncol; 2000 Apr; 11(4):483-5. PubMed ID: 10847471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon alpha 2a and vindesine in the treatment of advanced malignant melanoma.
    Smith KA; Green JA; Eccles JM
    Eur J Cancer; 1992; 28(2-3):438-41. PubMed ID: 1591059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of malignant melanoma at the stage of distant metastasis].
    Garbe C; Eigentler TK
    Hautarzt; 2004 Feb; 55(2):195-213. PubMed ID: 15043023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma].
    Mansat-Krzyzanowska E; Dreno B
    Ann Dermatol Venereol; 1994; 121(12):884-7. PubMed ID: 7632005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.
    Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Nishigori C
    Eur J Dermatol; 2018 Feb; 28(1):115-116. PubMed ID: 29171409
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of adrenal gland metastasis of a cutaneous melanoma treated by excision with 3-year survival].
    Claude R; Sale JM; Cavillon C; Rigondet G; Desplechain C; Egloff H; Franck F; Goujon N; Lautier A; Plagne R
    Ann Urol (Paris); 1996; 30(1):44-5. PubMed ID: 8712760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inefficacy of vindesine monotherapy in advanced stage IV malignant melanoma patients previously treated with other chemotherapeutic agents.
    Emmert S; Zutt M; Haenssle H; Neumann C; Kretschmer L
    Melanoma Res; 2003 Jun; 13(3):299-302. PubMed ID: 12777986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised trial of vindesine plus interferon-alpha 2b compared with interferon-alpha 2b or vindesine alone in the treatment of advanced malignant melanoma.
    Vorobiof DA; Bezwoda WR
    Eur J Cancer; 1994; 30A(6):797-800. PubMed ID: 7917540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dramatic remission of a multiple metastasized melanoma caused by chemo-immunotherapy].
    Hauschild A; Osterkamp G; Clausen M; Christophers E
    Dtsch Med Wochenschr; 1993 Mar; 118(10):336-40. PubMed ID: 8453902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
    Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
    Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
    Gibney GT; Atkins MB
    J Clin Oncol; 2015 Jun; 33(17):1873-7. PubMed ID: 25964248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse.
    Egberts F; Hitschler WN; Weichenthal M; Hauschild A
    Melanoma Res; 2009 Feb; 19(1):31-5. PubMed ID: 19104452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
    Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R
    Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histologic involvement of regional lymph nodes in malignant melanoma. Adjuvant vindesine improves survival.
    Retsas S; Quigley M; Pectasides D; Macrae K; Henry K
    Cancer; 1994 Apr; 73(8):2119-30. PubMed ID: 8156517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resection in the popliteal fossa for metastatic melanoma.
    Marone U; Caracò C; Chiofalo MG; Botti G; Mozzillo N
    World J Surg Oncol; 2007 Jan; 5():8. PubMed ID: 17239242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.
    Richtig E; Hofmann-Wellenhof R; Pehamberger H; Forstinger Ch; Wolff K; Mischer P; Raml J; Fritsch P; Zelger B; Ratzinger G; Koller J; Lang A; Konrad K; Kindermann-Glebowski E; Seeber A; Steiner A; Fialla R; Pachinger W; Kos C; Klein G; Kehrer H; Kerl H; Ulmer H; Smolle J
    Br J Dermatol; 2004 Jul; 151(1):91-8. PubMed ID: 15270876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarterial chemotherapy of malignant melanoma metastatic to the liver.
    Melichar B; Dvorák J; Jandík P; Tousková M; Solichová D; Megancová J; Voboril Z
    Hepatogastroenterology; 2001; 48(42):1711-5. PubMed ID: 11813606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.
    Terheyden P; Becker JC; Kämpgen E; Bröcker EB
    Melanoma Res; 2000 Oct; 10(5):475-82. PubMed ID: 11095409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
    Nuzzo C; Zeuli M; Ferraresi V; Ciccarese M; Pelligrini D; Cognetti F
    Anticancer Res; 2008; 28(2B):1429-31. PubMed ID: 18505091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant blue nevus of the scalp.
    Calista D; Schianchi S; Landi C
    Int J Dermatol; 1998 Feb; 37(2):126-7. PubMed ID: 9542669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.